These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study. Ziegler M; Castro-Caldas A; Del Signore S; Rascol O Mov Disord; 2003 Apr; 18(4):418-25. PubMed ID: 12671949 [TBL] [Abstract][Full Text] [Related]
31. [Experimental and clinical study on the dopaminergic receptor stimulating agents (author's transl)]. Ohmoto T; Miyamoto T; Baba Y No To Shinkei; 1977 Jul; 29(7):?31-40. PubMed ID: 409419 [No Abstract] [Full Text] [Related]
32. [D,L-threo-3,4-dihydroxyphenylserine (D,L-threo-DOPS) treatment on the patients with Parkinson's disease or pure akinesia]. Kondo T Rinsho Shinkeigaku; 1984 Mar; 24(3):280-8. PubMed ID: 6432393 [No Abstract] [Full Text] [Related]
34. A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease. Montastruc JL; Ziegler M; Rascol O; Malbezin M Mov Disord; 1999 Mar; 14(2):336-41. PubMed ID: 10091630 [TBL] [Abstract][Full Text] [Related]
35. Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation. Smith LA; Tel BC; Jackson MJ; Hansard MJ; Braceras R; Bonhomme C; Chezaubernard C; Del Signore S; Rose S; Jenner P Mov Disord; 2002 Sep; 17(5):887-901. PubMed ID: 12360537 [TBL] [Abstract][Full Text] [Related]
36. [Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study]. Fedorova NV Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):21-4. PubMed ID: 14681961 [TBL] [Abstract][Full Text] [Related]
37. [The use of piribedil in early and late stages of Parkinson's disease]. Fedorova NV; Kulua TK; Gubanova ЕN Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):96-98. PubMed ID: 26525631 [TBL] [Abstract][Full Text] [Related]
38. Piribedil: sleep attacks, also in patients without Parkinson's disease. Prescrire Int; 2013 Nov; 22(143):265. PubMed ID: 24427837 [TBL] [Abstract][Full Text] [Related]
39. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease. Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P; Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842 [TBL] [Abstract][Full Text] [Related]
40. [The agonist of dopamine receptors piribedil in treatment of Parkinson's disease]. Pilipovich AA; Golubev VL Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):83-90. PubMed ID: 28745677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]